MIMS Online
@mimsonline
Followers
2K
Following
171
Media
454
Statuses
5K
MIMS is the prescribing reference for healthcare professionals. Sign up for our email alerts at https://t.co/rxCFwPvEXy
Joined November 2010
Commonly available preparations to treat acute otitis externa in primary care are summarised in a handy table in an updated MIMS Learning module. Find out more about what the module has to say about antibiotic prescribing for this condition on MIMS https://t.co/AygBavfVZa
mims.co.uk
0
0
0
This week's news in brief ▶️ Branded antispasmodics discontinued ▶️ Third SGLT2 inhibitor licensed for paediatric use ▶️ Isosorbide mononitrate modified-release tablets available in new strength Read more on MIMS https://t.co/rcEJtNZa8m
0
0
0
GLP-1 agonists are associated with an increased risk of new chronic cough in people with type II diabetes, according to a large, multicentre, cohort study. Read more on MIMS https://t.co/tIpEHjSq7s
mims.co.uk
0
0
0
This week's #DrugShortages ▶️ Almuriva 4.6mg/24hr, 9.5mg/24hr and 13.3mg/24hr patches (rivastigmine) For more information, see the MIMS Drug Shortages Tracker https://t.co/v26g2iKiyH
0
0
0
After an almost 3-year effort, @Haymarket_Media is now B Corp Certified on a global scale. This milestone formalises the company’s deep commitment to balancing profit with purpose to benefit its people, customers, communities and the planet. https://t.co/fwSce8hcrC
haymarket.com
The media, data & information company certifies on an international scale Haymarket Media Group, the global media, data and information business, today announces it has achieved B Corp certification...
0
2
2
Methylphenidate availability for ADHD prescribing has improved with the launch of a new preparation, and a new chewable version is set to launch next year. Find out more on MIMS Pharma https://t.co/pUM1VVeJ1z
mimspharma.co.uk
The availability of methylphenidate for ADHD prescribing has improved with the launch of a new product, resupply of an existing preparation, and a new chewable version set to launch next year.
0
0
0
Pharmacological therapy in people with COPD should now be escalated after a moderate, rather than a severe, exacerbation, the draft 2026 GOLD report recommends. Read more on MIMS https://t.co/5InDyi3kbS
0
0
0
This week's news in brief ▶️ Tirzepatide highly effective for weight loss in PCOS Read more on MIMS https://t.co/rcEJtNZa8m
0
0
1
Antihypertensives should be deprescribed in older people with severe frailty because the harms of the medications probably outweigh the benefits, the British Geriatrics Society has advised. Read more on MIMS https://t.co/Ci4zjtVhVz
0
0
0
This week's #drugshortages ▶️ Imigran Nasal Spray, 10mg/0.1ml x 2 and 20mg/0.1ml x 6 (sumatriptan) ▶️ Metosyn 0.05% ointment (fluocinonide) ▶️ Prostin E2 (dinoprostone) For more information, see the MIMS Drug Shortages dashboard https://t.co/5ioprFvJ8o
0
0
0
Ibandronic acid 150mg tablets, the only licensed once monthly bisphosphonate, are in limited supply until March 2026. Read more on MIMS https://t.co/EUkoX4tuJ6
0
0
0
The long-acting β2 agonist/corticosteroid (LABA/ICS) inhaler Vivaire (formoterol/beclometasone) is being discontinued. Read more on MIMS https://t.co/AmI3uIj0vi
0
0
0
This week's news in brief ▶️ A cup of #coffee a day may cut risk of recurrent #atrialfibrillation Read more on MIMS https://t.co/fjziVT4M9q
0
0
0
This week's #drugshortages ▶️ Hemabate (carboprost) ▶️ Mirapexin 88 microgram, 180 microgram and 350 microgram tablets (pramipexole) For more information, see the MIMS Drug Shortages tracker https://t.co/0lpIaLfwH6
0
0
0
Propranolol 80mg and 160mg modified-release capsules will be subject to supply disruption until 2026. Read more on MIMS https://t.co/12cxJTfe5O
0
0
0
The MHRA has approved low-dose atropine eye drops to slow the progression of myopia in children. Read more on #MIMSPharma
https://t.co/CXilkXTTIG
0
0
0
Patients from minority ethnic groups should have the right to request to see the same GP for menopause follow-ups and the option to see a female GP, according to a new report from the APPG on menopause. Find out more on MIMS https://t.co/wXTqOSYcTa
mims.co.uk
0
0
0
This week's news in brief. ▶️ Desogestrel-based contraceptives linked to higher risk of breast cancer than other contraceptives Read more on MIMS https://t.co/lJKZDolVJq
0
0
0
Influenza is now circulating in the community with earlier than usual onset of activity, and with an A(H3N2) drifted strain (K, also known as J.2.4.1) predominating, the UKHSA and DHSC have warned Read more on MIMS https://t.co/dTaWmhdE1t
0
0
1
Delgocitinib (Anzupgo) has been recommended by NICE as a new treatment option for adults with moderate to severe chronic hand eczema. Read more on MIMS https://t.co/8kptaA4C5W
0
0
0